The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment (original) (raw)

• Halder, G. & Johnson, R. L. Hippo signaling: growth control and beyond. Development 138, 9–22 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Staley, B. K. & Irvine, K. D. Hippo signaling in Drosophila: recent advances and insights. Dev. Dyn. 241, 3–15 (2012).
  Article CAS PubMed Google Scholar
• Genevet, A. & Tapon, N. The Hippo pathway and apico-basal cell polarity. Biochem. J. 436, 213–224 (2011).
  Article CAS PubMed Google Scholar
• Ramos, A. & Camargo, F. D. The Hippo signaling pathway and stem cell biology. Trends Cell Biol. 22, 339–346 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Pan, D. The hippo signaling pathway in development and cancer. Dev. Cell 19, 491–505 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Yu, F. X. & Guan, K. L. The Hippo pathway: regulators and regulations. Genes Dev. 27, 355–371 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Harvey, K. F., Zhang, X. & Thomas, D. M. The Hippo pathway and human cancer. Nature Rev. Cancer 13, 246–257 (2013).
  Article CAS Google Scholar
• Stanger, B. Z. Quit your YAPing: a new target for cancer therapy. Genes Dev. 26, 1263–1267 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Liu, A. M., Xu, Z. & Luk, J. M. An update on targeting Hippo-YAP signaling in liver cancer. Expert Opin. Ther. Targets 16, 243–247 (2012).
  Article CAS PubMed Google Scholar
• Hong, W. & Guan, K. L. The YAP and TAZ transcription co-activators: key downstream effectors of the mammalian Hippo pathway. Semin. Cell Dev. Biol. 23, 785–793 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Dong, J. et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 130, 1120–1133 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Camargo, F. D. et al. YAP1 increases organ size and expands undifferentiated progenitor cells. Curr. Biol. 17, 2054–2060 (2007).
  Article CAS PubMed Google Scholar
• Wang, Y. et al. Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer. Cancer Sci. 101, 1279–1285 (2010).
  Article CAS PubMed Google Scholar
• Zhou, Z. et al. TAZ is a novel oncogene in non-small cell lung cancer. Oncogene 30, 2181–2186 (2011).
  Article CAS PubMed Google Scholar
• Overholtzer, M. et al. Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc. Natl Acad. Sci. USA 103, 12405–12410 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Zender, L. et al. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 125, 1253–1267 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Steinhardt, A. A. et al. Expression of Yes-associated protein in common solid tumors. Hum. Pathol. 39, 1582–1589 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Chan, S. W. et al. A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells. Cancer Res. 68, 2592–2598 (2008).
  Article CAS PubMed Google Scholar
• Fernandez, L. A. et al. YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation. Genes Dev. 23, 2729–2741 (2009).
  Article CAS Google Scholar
• Xu, M. Z. et al. Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer 115, 4576–4585 (2009).
  Article CAS PubMed Google Scholar
• Zhao, B. et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 21, 2747–2761 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Cai, J. et al. The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. Genes Dev. 24, 2383–2388 (2010). This study shows that YAP levels are elevated during the regeneration of damaged mouse intestinal crypts after injury by DSS and that YAP is essential for crypt regeneration, but its loss causes no obvious defects during normal homeostasis.
  Article CAS PubMed PubMed Central Google Scholar
• Grusche, F. A., Degoutin, J. L., Richardson, H. E. & Harvey, K. F. The Salvador/Warts/Hippo pathway controls regenerative tissue growth in Drosophila melanogaster. Dev. Biol. 350, 255–266 (2011).
  Article CAS PubMed Google Scholar
• Staley, B. K. & Irvine, K. D. Warts and Yorkie mediate intestinal regeneration by influencing stem cell proliferation. Curr. Biol. 20, 1580–1587 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Shaw, R. L. et al. The Hippo pathway regulates intestinal stem cell proliferation during Drosophila adult midgut regeneration. Development 137, 4147–4158 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Karpowicz, P., Perez, J. & Perrimon, N. The Hippo tumor suppressor pathway regulates intestinal stem cell regeneration. Development 137, 4135–4145 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Ren, F. et al. Hippo signaling regulates Drosophila intestine stem cell proliferation through multiple pathways. Proc. Natl Acad. Sci. USA 107, 21064–21069 (2010).
  Article PubMed PubMed Central Google Scholar
• Xin, M. et al. Hippo pathway effector Yap promotes cardiac regeneration. Proc. Natl Acad. Sci. USA 110, 13839–13844 (2013).
  Article PubMed PubMed Central Google Scholar
• Heallen, T. et al. Hippo signaling impedes postnatal cardiomyocyte regeneration. Development 140, 4683–4690 (2013). References 28 and 29 show that YAP is required for postnatal cardiac growth and neonatal cardiac regeneration, and that the expression of a constitutively active form of YAP or deletion of Hippo pathway components in the adult heart stimulates cardiac regeneration after myocardial infarction.
  Article CAS PubMed PubMed Central Google Scholar
• Sun, G. & Irvine, K. D. Regulation of Hippo signaling by Jun kinase signaling during compensatory cell proliferation and regeneration, and in neoplastic tumors. Dev. Biol. 350, 139–151 (2011).
  Article CAS PubMed Google Scholar
• Schroeder, M. C. & Halder, G. Regulation of the Hippo pathway by cell architecture and mechanical signals. Semin. Cell Dev. Biol. 23, 803–811 (2012).
  Article CAS PubMed Google Scholar
• Udan, R. S., Kango-Singh, M., Nolo, R., Tao, C. & Halder, G. Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway. Nature Cell Biol. 5, 914–920 (2003).
  Article CAS PubMed Google Scholar
• Harvey, K. F., Pfleger, C. M. & Hariharan, I. K. The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis. Cell 114, 457–467 (2003).
  Article CAS PubMed Google Scholar
• Pantalacci, S., Tapon, N. & Leopold, P. The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila. Nature Cell Biol. 5, 921–927 (2003).
  Article CAS PubMed Google Scholar
• Wu, S., Huang, J., Dong, J. & Pan, D. Hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts. Cell 114, 445–456 (2003).
  Article CAS PubMed Google Scholar
• Jia, J., Zhang, W., Wang, B., Trinko, R. & Jiang, J. The Drosophila Ste20 family kinase dMST functions as a tumor suppressor by restricting cell proliferation and promoting apoptosis. Genes Dev. 17, 2514–2519 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Justice, R. W., Zilian, O., Woods, D. F., Noll, M. & Bryant, P. J. The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. Genes Dev. 9, 534–546 (1995).
  Article CAS PubMed Google Scholar
• Xu, T., Wang, W., Zhang, S., Stewart, R. A. & Yu, W. Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. Development 121, 1053–1063 (1995).
  CAS PubMed Google Scholar
• Creasy, C. L. & Chernoff, J. Cloning and characterization of a member of the MST subfamily of Ste20-like kinases. Gene 167, 303–306 (1995).
  Article CAS PubMed Google Scholar
• Creasy, C. L. & Chernoff, J. Cloning and characterization of a human protein kinase with homology to Ste20. J. Biol. Chem. 270, 21695–21700 (1995).
  Article CAS PubMed Google Scholar
• Taylor, L. K., Wang, H. C. & Erikson, R. L. Newly identified stress-responsive protein kinases, Krs-1 and Krs-2. Proc. Natl Acad. Sci. USA 93, 10099–10104 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Tapon, N. et al. Salvador promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell 110, 467–478 (2002).
  Article CAS PubMed Google Scholar
• Kango-Singh, M. et al. Shar-pei mediates cell proliferation arrest during imaginal disc growth in Drosophila. Development 129, 5719–5730 (2002).
  Article CAS PubMed Google Scholar
• Lai, Z. C. et al. Control of cell proliferation and apoptosis by mob as tumor suppressor, mats. Cell 120, 675–685 (2005).
  Article CAS PubMed Google Scholar
• Huang, J., Wu, S., Barrera, J., Matthews, K. & Pan, D. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell 122, 421–434 (2005).
  Article CAS PubMed Google Scholar
• Goulev, Y. et al. SCALLOPED interacts with YORKIE, the nuclear effector of the hippo tumor-suppressor pathway in Drosophila. Curr. Biol. 18, 435–441 (2008).
  Article CAS PubMed Google Scholar
• Wu, S., Liu, Y., Zheng, Y., Dong, J. & Pan, D. The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway. Dev. Cell 14, 388–398 (2008).
  Article CAS PubMed Google Scholar
• Zhang, L. et al. The TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control. Dev. Cell 14, 377–387 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Zhao, B. et al. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 22, 1962–1971 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Vassilev, A., Kaneko, K. J., Shu, H., Zhao, Y. & DePamphilis, M. L. TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm. Genes Dev. 15, 1229–1241 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Alarcon, C. et al. Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-β pathways. Cell 139, 757–769 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Varelas, X. et al. TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nature Cell Biol. 10, 837–848 (2008).
  Article CAS PubMed Google Scholar
• Ferrigno, O. et al. Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-β/Smad signaling. Oncogene 21, 4879–4884 (2002).
  Article CAS PubMed Google Scholar
• Murakami, M., Nakagawa, M., Olson, E. N. & Nakagawa, O. A. WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome. Proc. Natl Acad. Sci. USA 102, 18034–18039 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Rosenbluh, J. et al. β-catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis. Cell 151, 1457–1473 (2012). This paper shows that YAP forms a complex with β-catenin and the transcription factor TBX5 in β-catenin-dependent cancer cell lines. The formation of this complex requires phosphorylation of YAP by YES1; dasatinib inhibits YES1 function and impedes the proliferation of β-catenin-dependent cancers in cell lines and animal models.
  Article CAS PubMed PubMed Central Google Scholar
• Yagi, R., Chen, L. F., Shigesada, K., Murakami, Y. & Ito, Y. A. WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator. EMBO J. 18, 2551–2562 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Strano, S. et al. Physical interaction with Yes-associated protein enhances p73 transcriptional activity. J. Biol. Chem. 276, 15164–15173 (2001).
  Article CAS PubMed Google Scholar
• Callus, B. A., Verhagen, A. M. & Vaux, D. L. Association of mammalian sterile twenty kinases, Mst1 and Mst2, with hSalvador via C-terminal coiled-coil domains, leads to its stabilization and phosphorylation. FEBS J. 273, 4264–4276 (2006).
  Article CAS PubMed Google Scholar
• Praskova, M., Xia, F. & Avruch, J. MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation. Curr. Biol. 18, 311–321 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Chan, E. H. et al. The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. Oncogene 24, 2076–2086 (2005).
  Article CAS PubMed Google Scholar
• Wei, X., Shimizu, T. & Lai, Z. C. Mob as tumor suppressor is activated by Hippo kinase for growth inhibition in Drosophila. EMBO J. 26, 1772–1781 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Lei, Q. Y. et al. TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway. Mol. Cell. Biol. 28, 2426–2436 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Oh, H. & Irvine, K. D. In vivo regulation of Yorkie phosphorylation and localization. Development 135, 1081–1088 (2008).
  Article CAS PubMed Google Scholar
• Hao, Y., Chun, A., Cheung, K., Rashidi, B. & Yang, X. Tumor suppressor LATS1 is a negative regulator of oncogene YAP. J. Biol. Chem. 283, 5496–5509 (2008).
  Article CAS PubMed Google Scholar
• Oka, T., Mazack, V. & Sudol, M. Mst2 and Lats kinases regulate apoptotic function of Yes kinase-associated protein (YAP). J. Biol. Chem. 283, 27534–27546 (2008).
  Article CAS PubMed Google Scholar
• Kanai, F. et al. TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J. 19, 6778–6791 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Ren, F., Zhang, L. & Jiang, J. Hippo signaling regulates Yorkie nuclear localization and activity through 14-3-3 dependent and independent mechanisms. Dev. Biol. 337, 303–312 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Liu, C. Y. et al. The Hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCFβ-TrCP E3 ligase. J. Biol. Chem. 285, 37159–37169 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Zhao, B., Li, L., Tumaneng, K., Wang, C. Y. & Guan, K. L. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCFβ-TRCP. Genes Dev. 24, 72–85 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Koontz, L. M. et al. The Hippo effector Yorkie controls normal tissue growth by antagonizing scalloped-mediated default repression. Dev. Cell 25, 388–401 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Guo, T. et al. A novel partner of Scalloped regulates Hippo signaling via antagonizing Scalloped-Yorkie activity. Cell Res. 23, 1201–1214 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Ota, M. & Sasaki, H. Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling. Development 135, 4059–4069 (2008).
  Article CAS PubMed Google Scholar
• Chan, S. W. et al. TEADs mediate nuclear retention of TAZ to promote oncogenic transformation. J. Biol. Chem. 284, 14347–14358 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Peng, H. W., Slattery, M. & Mann, R. S. Transcription factor choice in the Hippo signaling pathway: homothorax and yorkie regulation of the microRNA bantam in the progenitor domain of the Drosophila eye imaginal disc. Genes Dev. 23, 2307–2319 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, H. et al. TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition. J. Biol. Chem. 284, 13355–13362 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Oh, H. & Irvine, K. D. Cooperative regulation of growth by Yorkie and Mad through bantam. Dev. Cell 20, 109–122 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Bazellieres, E., Assemat, E., Arsanto, J. P., Le Bivic, A. & Massey-Harroche, D. Crumbs proteins in epithelial morphogenesis. Front. Biosci. 14, 2149–2169 (2009).
  Article CAS Google Scholar
• Varelas, X. et al. The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-β-SMAD pathway. Dev. Cell 19, 831–844 (2010).
  Article CAS PubMed Google Scholar
• Chen, C. L. et al. The apical-basal cell polarity determinant Crumbs regulates Hippo signaling in Drosophila. Proc. Natl Acad. Sci. USA 107, 15810–15815 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Robinson, B. S., Huang, J., Hong, Y. & Moberg, K. H. Crumbs regulates Salvador/Warts/Hippo signaling in Drosophila via the FERM-domain protein expanded. Curr. Biol. 20, 582–590 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Grzeschik, N. A., Parsons, L. M., Allott, M. L., Harvey, K. F. & Richardson, H. E. Lgl, aPKC, and Crumbs regulate the Salvador/Warts/Hippo pathway through two distinct mechanisms. Curr. Biol. 20, 573–581 (2010).
  Article CAS PubMed Google Scholar
• Ling, C. et al. The apical transmembrane protein Crumbs functions as a tumor suppressor that regulates Hippo signaling by binding to Expanded. Proc. Natl Acad. Sci. USA 107, 10532–10537 (2010).
  Article PubMed PubMed Central Google Scholar
• Chan, S. W. et al. Hippo pathway-independent restriction of TAZ and YAP by angiomotin. J. Biol. Chem. 286, 7018–7026 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Hirate, Y. et al. Polarity-dependent distribution of angiomotin localizes Hippo signaling in preimplantation embryos. Curr. Biol. 23, 1181–1194 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Zhao, B. et al. Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev. 25, 51–63 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, W., Huang, J. & Chen, J. Angiomotin-like proteins associate with and negatively regulate YAP1. J. Biol. Chem. 286, 4364–4370 (2011).
  Article CAS PubMed Google Scholar
• Paramasivam, M., Sarkeshik, A., Yates, J. R., Fernandes, M. J. & McCollum, D. Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor. Mol. Biol. Cell 22, 3725–3733 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Yi, C. et al. A tight junction-associated Merlin-angiomotin complex mediates Merlin's regulation of mitogenic signaling and tumor suppressive functions. Cancer Cell 19, 527–540 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Yi, C. et al. The p130 isoform of angiomotin is required for Yap-mediated hepatic epithelial cell proliferation and tumorigenesis. Sci. Signal. 6, ra77 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Boggiano, J. C., Vanderzalm, P. J. & Fehon, R. G. Tao-1 phosphorylates Hippo/MST kinases to regulate the Hippo-Salvador-Warts tumor suppressor pathway. Dev. Cell 21, 888–895 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Poon, C. L., Lin, J. I., Zhang, X. & Harvey, K. F. The sterile 20-like kinase Tao-1 controls tissue growth by regulating the Salvador-Warts-Hippo pathway. Dev. Cell 21, 896–906 (2011).
  Article CAS PubMed Google Scholar
• Huang, H. L. et al. Par-1 regulates tissue growth by influencing Hippo phosphorylation status and Hippo-salvador association. PLoS Biol. 11, e1001620 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Genevet, A., Wehr, M. C., Brain, R., Thompson, B. J. & Tapon, N. Kibra is a regulator of the Salvador/Warts/Hippo signaling network. Dev. Cell 18, 300–308 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Yu, J. et al. Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded. Dev. Cell 18, 288–299 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Baumgartner, R., Poernbacher, I., Buser, N., Hafen, E. & Stocker, H. The WW domain protein Kibra acts upstream of Hippo in Drosophila. Dev. Cell 18, 309–316 (2010).
  Article CAS PubMed Google Scholar
• Hamaratoglu, F. et al. The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis. Nature Cell Biol. 8, 27–36 (2006).
  Article CAS PubMed Google Scholar
• Sansores-Garcia, L. et al. Modulating F-actin organization induces organ growth by affecting the Hippo pathway. EMBO J. 30, 2325–2335 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Fernandez, B. G. et al. Actin-capping protein and the Hippo pathway regulate F-actin and tissue growth in Drosophila. Development 138, 2337–2346 (2011).
  Article CAS PubMed Google Scholar
• Dupont, S. et al. Role of YAP/TAZ in mechanotransduction. Nature 474, 179–183 (2011).
  Article CAS PubMed Google Scholar
• Wada, K., Itoga, K., Okano, T., Yonemura, S. & Sasaki, H. Hippo pathway regulation by cell morphology and stress fibers. Development 138, 3907–3914 (2011). References 96–100 show that YAP activity is regulated by the amount of F-actin stress fibres, by the mechanical properties of the extracellular matrix and by cell geometry. Disruption of F-actin stress fibres or of actin contractility by small-molecule inhibitors suppresses the nuclear localization and activity of YAP.
  Article CAS PubMed Google Scholar
• Zhao, B. et al. Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis. Genes Dev. 26, 54–68 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Yu, F. X. et al. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 150, 780–791 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Miller, E. et al. Identification of serum-derived sphingosine-1-phosphate as a small molecule regulator of YAP. Chem. Biol. 19, 955–962 (2012).
  Article CAS PubMed Google Scholar
• Mo, J. S., Yu, F. X., Gong, R., Brown, J. H. & Guan, K. L. Regulation of the Hippo-YAP pathway by protease-activated receptors (PARs). Genes Dev. 26, 2138–2143 (2012). References 101–103 show that GPCRs regulate the activity of the Hippo pathway, and that compounds and ligands that modulate GPCR activity affect YAP activity.
  Article CAS PubMed PubMed Central Google Scholar
• Aragona, M. et al. A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors. Cell 154, 1047–1059 (2013).
  Article CAS PubMed Google Scholar
• Kim, N. G., Koh, E., Chen, X. & Gumbiner, B. M. E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components. Proc. Natl Acad. Sci. USA 108, 11930–11935 (2011).
  Article PubMed PubMed Central Google Scholar
• Schlegelmilch, K. et al. Yap1 acts downstream of α-catenin to control epidermal proliferation. Cell 144, 782–795 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Silvis, M. R. et al. α-catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1. Sci. Signal. 4, ra33 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Das Thakur, M. et al. Ajuba LIM proteins are negative regulators of the Hippo signaling pathway. Curr. Biol. 20, 657–662 (2010).
  Article CAS PubMed Google Scholar
• Rauskolb, C., Pan, G., Reddy, B. V., Oh, H. & Irvine, K. D. Zyxin links fat signaling to the Hippo pathway. PLoS Biol. 9, e1000624 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Tepass, U. The apical polarity protein network in Drosophila epithelial cells: regulation of polarity, junctions, morphogenesis, cell growth, and survival. Annu. Rev. Cell Dev. Biol. 28, 655–685 (2012).
  Article CAS PubMed Google Scholar
• Muthuswamy, S. K. & Xue, B. Cell polarity as a regulator of cancer cell behavior plasticity. Annu. Rev. Cell Dev. Biol. 28, 599–625 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Brieher, W. M. & Yap, A. S. Cadherin junctions and their cytoskeleton(s). Curr. Opin. Cell Biol. 25, 39–46 (2013).
  Article CAS PubMed Google Scholar
• Twiss, F. & de Rooij, J. Cadherin mechanotransduction in tissue remodeling. Cell. Mol. Life Sci. (2013).
• Zhang, X., Milton, C. C., Poon, C. L., Hong, W. & Harvey, K. F. Wbp2 cooperates with Yorkie to drive tissue growth downstream of the Salvador-Warts-Hippo pathway. Cell Death Differ. 18, 1346–1355 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Chan, S. W. et al. WW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZ. Oncogene 30, 600–610 (2011).
  Article CAS PubMed Google Scholar
• Chen, H. I. et al. Characterization of the WW domain of human yes-associated protein and its polyproline-containing ligands. J. Biol. Chem. 272, 17070–17077 (1997).
  Article CAS PubMed Google Scholar
• Sidor, C. M., Brain, R. & Thompson, B. J. Mask proteins are cofactors of Yorkie/YAP in the Hippo pathway. Curr. Biol. 23, 223–228 (2013).
  Article CAS PubMed Google Scholar
• Sansores-Garcia, L. et al. Mask is required for the activity of the Hippo pathway effector Yki/YAP. Curr. Biol. 23, 229–235 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Remue, E. et al. TAZ interacts with zonula occludens-1 and -2 proteins in a PDZ-1 dependent manner. FEBS Lett. 584, 4175–4180 (2010).
  Article CAS PubMed Google Scholar
• Oka, T. et al. Functional complexes between YAP2 and ZO-2 are PDZ domain-dependent, and regulate YAP2 nuclear localization and signalling. Biochem. J. 432, 461–472 (2010).
  Article CAS PubMed Google Scholar
• Poon, C. L., Zhang, X., Lin, J. I., Manning, S. A. & Harvey, K. F. Homeodomain-interacting protein kinase regulates Hippo pathway-dependent tissue growth. Curr. Biol. 22, 1587–1594 (2012).
  Article CAS PubMed Google Scholar
• Chen, J. & Verheyen, E. M. Homeodomain-interacting protein kinase regulates Yorkie activity to promote tissue growth. Curr. Biol. 22, 1582–1586 (2012).
  Article CAS PubMed Google Scholar
• Liu, X. et al. PTPN14 interacts with and negatively regulates the oncogenic function of YAP. Oncogene 32, 1266–1273 (2013).
  Article CAS PubMed Google Scholar
• Wang, W. et al. PTPN14 is required for the density-dependent control of YAP1. Genes Dev. 26, 1959–1971 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Michaloglou, C. et al. The tyrosine phosphatase PTPN14 is a negative regulator of YAP activity. PLoS ONE 8, e61916 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Huang, J. M. et al. YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14. Oncogene 32, 2220–2229 (2013).
  Article CAS PubMed Google Scholar
• Poernbacher, I., Baumgartner, R., Marada, S. K., Edwards, K. & Stocker, H. Drosophila Pez acts in Hippo signaling to restrict intestinal stem cell proliferation. Curr. Biol. 22, 389–396 (2012).
  Article CAS PubMed Google Scholar
• Polesello, C., Huelsmann, S., Brown, N. H. & Tapon, N. The Drosophila RASSF homolog antagonizes the Hippo pathway. Curr. Biol. 16, 2459–2465 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Praskova, M., Khoklatchev, A., Ortiz-Vega, S. & Avruch, J. Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras. Biochem. J. 381, 453–462 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Ikeda, M. et al. Hippo pathway-dependent and -independent roles of RASSF6. Sci. Signal. 2, ra59 (2009).
  Article PubMed Google Scholar
• Ribeiro, P. S. et al. Combined functional genomic and proteomic approaches identify a PP2A complex as a negative regulator of Hippo signaling. Mol. Cell 39, 521–534 (2010).
  Article CAS PubMed Google Scholar
• Wehr, M. C. et al. Salt-inducible kinases regulate growth through the Hippo signalling pathway in Drosophila. Nature Cell Biol. 15, 61–71 (2013).
  Article CAS PubMed Google Scholar
• Yin, F. et al. Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2. Cell 154, 1342–1355 (2013).
  Article CAS PubMed Google Scholar
• Chen, C. L., Schroeder, M. C., Kango-Singh, M., Tao, C. & Halder, G. Tumor suppression by cell competition through regulation of the Hippo pathway. Proc. Natl Acad. Sci. USA 109, 484–489 (2012).
  Article PubMed Google Scholar
• Menendez, J., Perez-Garijo, A., Calleja, M. & Morata, G. A tumor-suppressing mechanism in Drosophila involving cell competition and the Hippo pathway. Proc. Natl Acad. Sci. USA 107, 14651–14656 (2010).
  Article PubMed PubMed Central Google Scholar
• Cordenonsi, M. et al. The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell 147, 759–772 (2011).
  Article CAS PubMed Google Scholar
• Zhao, M., Szafranski, P., Hall, C. A. & Goode, S. Basolateral junctions utilize warts signaling to control epithelial-mesenchymal transition and proliferation crucial for migration and invasion of Drosophila ovarian epithelial cells. Genetics 178, 1947–1971 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Bossuyt, W. et al. An evolutionary shift in the regulation of the Hippo pathway between mice and flies. Oncogene http://dx.doi.org/10.1038/onc.2013.82 (2013).
• Zhou, D. et al. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell 16, 425–438 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Lu, L. et al. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc. Natl Acad. Sci. USA 107, 1437–1442 (2010).
  Article PubMed PubMed Central Google Scholar
• Song, H. et al. Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proc. Natl Acad. Sci. USA 107, 1431–1436 (2010).
  Article PubMed PubMed Central Google Scholar
• Lee, K. P. et al. The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis. Proc. Natl Acad. Sci. USA 107, 8248–8253 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Zhou, D. et al. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proc. Natl Acad. Sci. USA 108, E1312–1320 (2011). Using mouse models, this paper reports that inactivation of a single YAP allele reverses hyperproliferation and expansion of the stem cell compartment as well as the loss of differentiated cell types in Mst1/Mst2 -null intestinal epithelia.
  Article PubMed PubMed Central Google Scholar
• George, N. M., Day, C. E., Boerner, B. P., Johnson, R. L. & Sarvetnick, N. E. Hippo signaling regulates pancreas development through inactivation of Yap. Mol. Cell. Biol. 32, 5116–5128 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Gao, T. et al. Hippo signaling regulates differentiation and maintenance in the exocrine pancreas. Gastroenterology 144, 1543–1553 (2013).
  Article CAS PubMed Google Scholar
• Heallen, T. et al. Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science 332, 458–461 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Yabuta, N. et al. N-terminal truncation of Lats1 causes abnormal cell growth control and chromosomal instability. J. Cell Sci. 126, 508–520 (2013).
  Article CAS PubMed Google Scholar
• Polesello, C. & Tapon, N. Salvador-warts-hippo signaling promotes Drosophila posterior follicle cell maturation downstream of notch. Curr. Biol. 17, 1864–1870 (2007).
  Article CAS PubMed Google Scholar
• Meignin, C., Alvarez-Garcia, I., Davis, I. & Palacios, I. M. The Salvador-Warts-Hippo pathway is required for epithelial proliferation and axis specification in Drosophila. Curr. Biol. 17, 1871–1878 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Bennett, F. C. & Harvey, K. F. Fat cadherin modulates organ size in Drosophila via the Salvador/Warts/Hippo signaling pathway. Curr. Biol. 16, 2101–2110 (2006).
  Article CAS PubMed Google Scholar
• Bryant, P. J. et al. Mutations at the fat locus interfere with cell proliferation control and epithelial morphogenesis in Drosophila. Dev. Biol. 129, 541–554 (1988).
  Article CAS PubMed Google Scholar
• Cho, E. et al. Delineation of a Fat tumor suppressor pathway. Nature Genet. 38, 1142–1150 (2006).
  Article CAS PubMed Google Scholar
• Silva, E., Tsatskis, Y., Gardano, L., Tapon, N. & McNeill, H. The tumor-suppressor gene fat controls tissue growth upstream of expanded in the Hippo signaling pathway. Curr. Biol. 16, 2081–2089 (2006).
  Article CAS PubMed Google Scholar
• Willecke, M. et al. The fat cadherin acts through the Hippo tumor-suppressor pathway to regulate tissue size. Curr. Biol. 16, 2090–2100 (2006).
  Article CAS PubMed Google Scholar
• MacDougall, N. et al. Merlin, the Drosophila homologue of neurofibromatosis-2, is specifically required in posterior follicle cells for axis formation in the oocyte. Development 128, 665–673 (2001).
  CAS PubMed Google Scholar
• Milton, C. C., Zhang, X., Albanese, N. O. & Harvey, K. F. Differential requirement of Salvador-Warts-Hippo pathway members for organ size control in Drosophila melanogaster. Development 137, 735–743 (2010).
  Article CAS PubMed Google Scholar
• Pellock, B. J., Buff, E., White, K. & Hariharan, I. K. The Drosophila tumor suppressors Expanded and Merlin differentially regulate cell cycle exit, apoptosis, and Wingless signaling. Dev. Biol. 304, 102–115 (2007).
  Article CAS PubMed Google Scholar
• Yu, J., Poulton, J., Huang, Y. C. & Deng, W. M. The Hippo pathway promotes Notch signaling in regulation of cell differentiation, proliferation, and oocyte polarity. PLoS ONE 3, e1761 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• McCartney, B. M., Kulikauskas, R. M., LaJeunesse, D. R. & Fehon, R. G. The neurofibromatosis-2 homologue, Merlin, and the tumor suppressor Expanded function together in Drosophila to regulate cell proliferation and differentiation. Development 127, 1315–1324 (2000).
  CAS PubMed Google Scholar
• von Gise, A. et al. YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy. Proc. Natl Acad. Sci. USA 109, 2394–2399 (2012).
  Article PubMed PubMed Central Google Scholar
• Xin, M. et al. Regulation of insulin-like growth factor signaling by Yap governs cardiomyocyte proliferation and embryonic heart size. Sci. Signal. 4, ra70 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, H., Pasolli, H. A. & Fuchs, E. Yes-associated protein (YAP) transcriptional coactivator functions in balancing growth and differentiation in skin. Proc. Natl Acad. Sci. USA 108, 2270–2275 (2011).
  Article PubMed PubMed Central Google Scholar
• Mikeladze-Dvali, T. et al. The growth regulators Warts/Lats and Melted interact in a bistable loop to specify opposite fates in Drosophila R8 photoreceptors. Cell 122, 775–787 (2005).
  Article CAS PubMed Google Scholar
• Nishioka, N. et al. The Hippo signaling pathway components Lats and Yap pattern Tead4 activity to distinguish mouse trophectoderm from inner cell mass. Dev. Cell 16, 398–410 (2009).
  Article CAS PubMed Google Scholar
• Oh, H. et al. Genome-wide association of Yorkie with chromatin and chromatin-remodeling complexes. Cell Rep. 3, 309–318 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Nagaraj, R. et al. Control of mitochondrial structure and function by the Yorkie/YAP oncogenic pathway. Genes Dev. 26, 2027–2037 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Kaneko, K. J. & Depamphilis, M. L. TEAD4 establishes the energy homeostasis essential for blastocoel formation. Development 140, 3680–3690 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Bhat, K. P. et al. The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma. Genes Dev. 25, 2594–2609 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Imanaka, Y. et al. MicroRNA-141 confers resistance to cisplatin-induced apoptosis by targeting YAP1 in human esophageal squamous cell carcinoma. J. Hum. Genet. 56, 270–276 (2011).
  Article CAS PubMed Google Scholar
• Kawahara, M. et al. Kpm/Lats2 is linked to chemosensitivity of leukemic cells through the stabilization of p73. Blood 112, 3856–3866 (2008).
  Article CAS PubMed Google Scholar
• Lai, D., Ho, K. C., Hao, Y. & Yang, X. Taxol resistance in breast cancer cells is mediated by the Hippo pathway component TAZ and its downstream transcriptional targets Cyr61 and CTGF. Cancer Res. 71, 2728–2738 (2011).
  Article CAS PubMed Google Scholar
• Huo, X. et al. Overexpression of Yes-associated protein confers doxorubicin resistance in hepatocellullar carcinoma. Oncol. Rep. 29, 840–846 (2013).
  Article CAS PubMed Google Scholar
• Urtasun, R. et al. Connective tissue growth factor autocriny in human hepatocellular carcinoma: oncogenic role and regulation by epidermal growth factor receptor/Yes-associated protein-mediated activation. Hepatology 54, 2149–2158 (2011).
  Article CAS PubMed Google Scholar
• Juric, V., Chen, C. C. & Lau, L. F. Fas-mediated apoptosis is regulated by the extracellular matrix protein CCN1 (CYR61) in vitro and in vivo. Mol. Cell. Biol. 29, 3266–3279 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Piccolo, S., Cordenonsi, M. & Dupont, S. Molecular pathways: YAP & TAZ take the centerstage in organ growth and tumorigenesis. Clin. Cancer Res. 19, 4925–4930 (2013).
  Article CAS PubMed Google Scholar
• Scheel, C. & Weinberg, R. A. Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin. Cancer Biol. 22, 396–403 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, N. et al. The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. Dev. Cell 19, 27–38 (2010). This study shows that heterozygous deletion of YAP significantly suppresses the overproliferation phenotypes resulting from loss of NF2 , which suggests that YAP is a potential drug target in cancers associated with NF2 inactivation.
  Article CAS PubMed PubMed Central Google Scholar
• Asthagiri, A. R. et al. Neurofibromatosis type 2. Lancet 373, 1974–1986 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Hanemann, C. O. Magic but treatable? Tumours due to loss of merlin. Brain 131, 606–615 (2008).
  Article CAS PubMed Google Scholar
• Murakami, H. et al. LATS2 is a tumor suppressor gene of malignant mesothelioma. Cancer Res. 71, 873–883 (2011).
  Article CAS PubMed Google Scholar
• Hall, C. A. et al. Hippo pathway effector Yap is an ovarian cancer oncogene. Cancer Res. 70, 8517–8525 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Baldwin, C., Garnis, C., Zhang, L., Rosin, M. P. & Lam, W. L. Multiple microalterations detected at high frequency in oral cancer. Cancer Res. 65, 7561–7567 (2005).
  Article CAS PubMed Google Scholar
• Snijders, A. M. et al. Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma. Oncogene 24, 4232–4242 (2005).
  Article CAS PubMed Google Scholar
• Modena, P. et al. Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics. J. Clin. Oncol. 24, 5223–5233 (2006).
  Article CAS PubMed Google Scholar
• Jiang, Z. et al. Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma. Neurosci. Res. 56, 450–458 (2006).
  Article CAS PubMed Google Scholar
• Takahashi, Y. et al. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers. Clin. Cancer Res. 11, 1380–1385 (2005).
  Article CAS PubMed Google Scholar
• Seidel, C. et al. Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma. Mol. Carcinog. 46, 865–871 (2007).
  Article CAS PubMed Google Scholar
• Li, H. et al. Deregulation of Hippo kinase signalling in human hepatic malignancies. Liver Int. 32, 38–47 (2012).
  Article CAS PubMed Google Scholar
• Zhang, T. et al. Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells. Hepatology 56, 2051–2059 (2012).
  Article CAS PubMed Google Scholar
• Wu, H. et al. The Ets transcription factor GABP is a component of the Hippo pathway essential for growth and antioxidant defense. Cell Rep. 3, 1663–1677 (2013).
  Article CAS PubMed Google Scholar
• Wang, J. et al. TRIB2 acts downstream of Wnt/TCF in liver cancer cells to regulate YAP and C/EBPα function. Mol. Cell 51, 211–225 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Konsavage, W. M. et al. Wnt/β-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells. J. Biol. Chem. 287, 11730–11739 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Liu-Chittenden, Y. et al. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Genes Dev. 26, 1300–1305 (2012). This paper shows that the expression of a dominant negative version of TEAD2 suppresses the overproliferation and tumorigenesis caused by YAP overexpression or inactivation of NF2, but it does not affect normal liver development. Furthermore, the authors identify the porphyrin family — particularly verteporfin — as inhibitors of the YAP–TEAD interaction and activity. Treatment of mice using verteporfin prevented liver overgrowth owing to YAP overexpression or to the activation of endogenous YAP in Nf2 -mutant livers.
  Article CAS PubMed PubMed Central Google Scholar
• Barry, E. R. et al. Restriction of intestinal stem cell expansion and the regenerative response by YAP. Nature 493, 106–110 (2013). This paper reports the surprising finding that in transgenic mice the overexpression of YAP in the colon reduces WNT expression and intestinal stem cell proliferation; conversely, loss of YAP results in WNT hypersensitivity during regeneration, possibly through a mechanism that involves sequestration of the WNT pathway component DVL by YAP in the cytoplasm.
  Article CAS PubMed Google Scholar
• Li, V. S. & Clevers, H. Intestinal regeneration: YAP-tumor suppressor and oncoprotein? Curr. Biol. 23, R110–R112 (2013).
  Article CAS PubMed Google Scholar
• Diep, C. H. et al. Down-regulation of Yes associated protein 1 expression reduces cell proliferation and clonogenicity of pancreatic cancer cells. PLoS ONE 7, e32783 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Lamar, J. M. et al. The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain. Proc. Natl Acad. Sci. USA 109, E2441–E2450 (2012).
  Article PubMed PubMed Central Google Scholar
• Zhou, Z., Zhu, J. S., Xu, Z. P. & Zhang, Q. Lentiviral vector-mediated siRNA knockdown of the YAP gene inhibits growth and induces apoptosis in the SGC7901 gastric cancer cell line. Mol. Med. Rep. 4, 1075–1082 (2011).
  CAS PubMed Google Scholar
• Wang, X., Su, L. & Ou, Q. Yes-associated protein promotes tumour development in luminal epithelial derived breast cancer. Eur. J. Cancer 48, 1227–1234 (2012).
  Article CAS PubMed Google Scholar
• Chen, D. et al. LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker. Nature Med. 18, 1511–1517 (2012).
  Article CAS PubMed Google Scholar
• Lavado, A. et al. Tumor suppressor Nf2 limits expansion of the neural progenitor pool by inhibiting Yap/Taz transcriptional coactivators. Development 140, 3323–3334 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Lian, I. et al. The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. Genes Dev. 24, 1106–1118 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Qin, H. et al. Transcriptional analysis of pluripotency reveals the Hippo pathway as a barrier to reprogramming. Hum. Mol. Genet. 21, 2054–2067 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Fellous, T. G. et al. Locating the stem cell niche and tracing hepatocyte lineages in human liver. Hepatology 49, 1655–1663 (2009).
  Article CAS PubMed Google Scholar
• Bergmann, O. et al. Evidence for cardiomyocyte renewal in humans. Science 324, 98–102 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Xu, M. Z. et al. AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma. Oncogene 30, 1229–1240 (2011).
  Article CAS PubMed Google Scholar
• Neesse, A. et al. CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer. Proc. Natl Acad. Sci. USA 110, 12325–12330 (2013).
  Article PubMed PubMed Central Google Scholar
• Zhang, J. et al. YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway. Nature Cell Biol. 11, 1444–1450 (2009).
  Article CAS PubMed Google Scholar
• Yang, N. et al. TAZ induces growth factor-independent proliferation through activation of EGFR ligand amphiregulin. Cell Cycle 11, 2922–2930 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Liu, A. M., Xu, M. Z., Chen, J., Poon, R. T. & Luk, J. M. Targeting YAP and Hippo signaling pathway in liver cancer. Expert Opin. Ther. Targets 14, 855–868 (2010).
  Article CAS PubMed Google Scholar
• Cohen, P. Protein kinases — the major drug targets of the twenty-first century? Nature Rev. Drug Discov. 1, 309–315 (2002).
  Article CAS Google Scholar
• Anand, R. et al. Toward the development of a potent and selective organoruthenium mammalian sterile 20 kinase inhibitor. J. Med. Chem. 52, 1602–1611 (2009). This paper reports on the development of a small-molecule inhibitor for the MST1 kinase that has high selectivity and that can serve as a starting point for developing improved MST1 inhibitors.
  Article CAS PubMed PubMed Central Google Scholar
• Ghose, A. K., Herbertz, T., Pippin, D. A., Salvino, J. M. & Mallamo, J. P. Knowledge based prediction of ligand binding modes and rational inhibitor design for kinase drug discovery. J. Med. Chem. 51, 5149–5171 (2008).
  Article CAS PubMed Google Scholar
• Norman, R. A., Toader, D. & Ferguson, A. D. Structural approaches to obtain kinase selectivity. Trends Pharmacol. Sci. 33, 273–278 (2012).
  Article CAS PubMed Google Scholar
• Chen, L. et al. Structural basis of YAP recognition by TEAD4 in the Hippo pathway. Genes Dev. 24, 290–300 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Li, Z. et al. Structural insights into the YAP and TEAD complex. Genes Dev. 24, 235–240 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Tian, W., Yu, J., Tomchick, D. R., Pan, D. & Luo, X. Structural and functional analysis of the YAP-binding domain of human TEAD2. Proc. Natl Acad. Sci. USA 107, 7293–7298 (2010).
  Article PubMed PubMed Central Google Scholar
• Fan, R., Kim, N. G. & Gumbiner, B. M. Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1. Proc. Natl Acad. Sci. USA 110, 2569–2574 (2013). This study shows that mitogenic growth factors such as EGF stimulate YAP nuclear accumulation and activity through PI3K and phosphoinositide-dependent kinase-1 (PDK1) signalling, which causes dissociation of a Hippo core complex. PI3K and PDK1 inhibitors, but not AKT inhibitors, inhibit YAP nuclear accumulation in several cultured cell lines.
  Article PubMed PubMed Central Google Scholar
• Strassburger, K., Tiebe, M., Pinna, F., Breuhahn, K. & Teleman, A. A. Insulin/IGF signaling drives cell proliferation in part via Yorkie/YAP. Dev. Biol. 367, 187–196 (2012).
  Article CAS PubMed Google Scholar
• Yu, F. X. et al. Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation. Genes Dev. 27, 1223–1232 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Bao, Y. et al. A cell-based assay to screen stimulators of the Hippo pathway reveals the inhibitory effect of dobutamine on the YAP-dependent gene transcription. J. Biochem. 150, 199–208 (2011). Using the intracellular localization of a green fluorescent protein (GFP)–YAP fusion protein in osteosarcoma cells as a read-out, the authors conducted a small-scale screen and identified the G protein-coupled β-adrenergic receptor agonist dobutamine as an inhibitor of YAP nuclear localization and activity.
  Article CAS PubMed Google Scholar
• Oudhoff, M. J. et al. Control of the Hippo pathway by Set7-dependent methylation of Yap. Dev. Cell 26, 188–194 (2013).
  Article CAS PubMed Google Scholar
• Hata, S. et al. A novel acetylation cycle of transcription co-activator Yes-associated protein that is downstream of Hippo pathway is triggered in response to SN2 alkylating agents. J. Biol. Chem. 287, 22089–22098 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Mao, B. et al. SIRT1 regulates YAP2-mediated cell proliferation and chemoresistance in hepatocellular carcinoma. Oncogene http://dx.doi.org/10.1038/onc.2013.88 (2013).